Varian Medical Systems, Inc. (VAR) Is At $109.55 Formed Wedge; Profile of 6 Analysts Covering Ameriprise Financial, Inc. (AMP)

Among 13 analysts covering Ameriprise Financial (NYSE:AMP), 6 have Buy rating, 0 Sell and 7 Hold. Therefore 46% are positive. Ameriprise Financial had 39 analyst reports since September 7, 2015 according to SRatingsIntel. On Monday, January 11 the stock rating was upgraded by Credit Suisse to “Outperform”. Barclays Capital maintained it with “Equal-Weight” rating and $99 target in Friday, January 29 report. The stock of Ameriprise Financial, Inc. (NYSE:AMP) earned “Hold” rating by RBC Capital Markets on Wednesday, October 25. Deutsche Bank downgraded the stock to “Hold” rating in Friday, October 14 report. The rating was maintained by Keefe Bruyette & Woods on Monday, October 12 with “Outperform”. The stock of Ameriprise Financial, Inc. (NYSE:AMP) earned “Market Perform” rating by Wells Fargo on Wednesday, January 13. The firm has “Neutral” rating given on Friday, October 7 by Credit Suisse. As per Monday, December 19, the company rating was downgraded by SunTrust. Keefe Bruyette & Woods maintained it with “Buy” rating and $14700 target in Friday, June 23 report. The firm has “Buy” rating given on Thursday, December 21 by Keefe Bruyette & Woods. See Ameriprise Financial, Inc. (NYSE:AMP) latest ratings:

21/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $190.0 Maintain
15/12/2017 Broker: RBC Capital Markets Rating: Hold New Target: $168.0 Maintain
13/11/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $165 New Target: $167 Maintain
26/10/2017 Broker: SunTrust Rating: Hold Old Target: $140 New Target: $165 Maintain
25/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $155.0 Maintain
18/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $149.0 Maintain
05/10/2017 Broker: Morgan Stanley Rating: Overweight Old Target: $152 New Target: $162 Maintain
11/08/2017 Broker: Barclays Capital Rating: Equal-Weight Old Target: $130 New Target: $142 Maintain
02/08/2017 Broker: Citigroup Rating: Buy New Target: $166.0000
27/07/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $155.0000 Maintain

Varian Medical Systems, Inc. (VAR) formed wedge up with $116.12 target or 6.00% above today’s $109.55 share price. Varian Medical Systems, Inc. (VAR) has $10.04B valuation. The stock increased 0.21% or $0.23 during the last trading session, reaching $109.55. About 21,727 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since January 18, 2017 and is uptrending. It has outperformed by 12.76% the S&P500.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.15, from 1.12 in 2017Q2. It is negative, as 35 investors sold Ameriprise Financial, Inc. shares while 228 reduced holdings. 76 funds opened positions while 178 raised stakes. 116.09 million shares or 1.34% more from 114.55 million shares in 2017Q2 were reported. Ajo L P reported 0.63% in Ameriprise Financial, Inc. (NYSE:AMP). Tiaa Cref Investment Management Ltd has invested 0.16% of its portfolio in Ameriprise Financial, Inc. (NYSE:AMP). Savant Lc accumulated 0.11% or 3,179 shares. Gamco Inc Et Al holds 23,950 shares or 0.02% of its portfolio. Jefferies Group Incorporated Limited Liability accumulated 9,413 shares or 0.01% of the stock. 43,379 are owned by Zurcher Kantonalbank (Zurich Cantonalbank). Westpac Bk holds 0.03% of its portfolio in Ameriprise Financial, Inc. (NYSE:AMP) for 9,931 shares. Farmers And Merchants Inc invested in 22,159 shares. Sei invested 0.09% of its portfolio in Ameriprise Financial, Inc. (NYSE:AMP). Aureus Asset Mgmt Ltd has invested 0.04% in Ameriprise Financial, Inc. (NYSE:AMP). Smith Asset Mgmt Grp Limited Partnership accumulated 0.5% or 100,860 shares. Metropolitan Life Ins reported 0.07% in Ameriprise Financial, Inc. (NYSE:AMP). Canandaigua National Bank & invested in 0.04% or 1,509 shares. Thrivent Fincl For Lutherans has 0% invested in Ameriprise Financial, Inc. (NYSE:AMP) for 5,950 shares. The Rhode Island-based Amica Mutual Insur has invested 0.13% in Ameriprise Financial, Inc. (NYSE:AMP).

Since July 31, 2017, it had 0 buys, and 15 selling transactions for $35.61 million activity. $5.70M worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by CRACCHIOLO JAMES M on Monday, August 14. $282,412 worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by Maglaque Charles Neal on Friday, October 27. Woerner John Robert had sold 9,022 shares worth $1.45M on Thursday, October 26. $396,205 worth of Ameriprise Financial, Inc. (NYSE:AMP) was sold by Kupper Randy on Friday, October 27. TRUSCOTT WILLIAM F sold $2.86 million worth of Ameriprise Financial, Inc. (NYSE:AMP) on Monday, July 31. 425 Ameriprise Financial, Inc. (NYSE:AMP) shares with value of $61,690 were sold by THISSEN KAREN WILSON. The insider Sweeney Joseph Edward sold $307,648.

The stock increased 1.19% or $2.1299 during the last trading session, reaching $180.5999. About 86,831 shares traded. Ameriprise Financial, Inc. (NYSE:AMP) has risen 30.25% since January 18, 2017 and is uptrending. It has outperformed by 13.55% the S&P500.

Ameriprise Financial, Inc., through its subsidiaries, provides various financial services and products to individual and institutional clients in the United States and internationally. The company has market cap of $26.72 billion. The companyÂ’s Advice & Wealth Management segment provides financial planning and advice, as well as full-service brokerage services primarily to retail clients through its advisors. It has a 16.88 P/E ratio. The Company’s Asset Management segment offers investment management and advice, and investment products to retail, high net worth, and institutional clients through unaffiliated third party financial institutions and institutional sales force.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on January, 24 after the close. They expect $0.99 EPS, up 32.00% or $0.24 from last year’s $0.75 per share. VAR’s profit will be $90.70M for 27.66 P/E if the $0.99 EPS becomes a reality. After $1.09 actual EPS reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -9.17% negative EPS growth.

Among 11 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 3 have Buy rating, 1 Sell and 7 Hold. Therefore 27% are positive. Varian Medical Systems Inc. has $121 highest and $75 lowest target. $99’s average target is -9.63% below currents $109.55 stock price. Varian Medical Systems Inc. had 31 analyst reports since August 27, 2015 according to SRatingsIntel. The firm has “Sell” rating by Goldman Sachs given on Monday, September 28. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Hold” rating given on Monday, August 28 by Robert W. Baird. On Wednesday, September 28 the stock rating was maintained by Robert W. Baird with “Neutral”. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Outperform” rating given on Friday, January 27 by Barrington Research. The firm has “Neutral” rating given on Tuesday, October 20 by Robert W. Baird. The stock has “Hold” rating by RBC Capital Markets on Friday, September 1. The rating was initiated by Citigroup with “Neutral” on Thursday, November 12. The rating was maintained by Robert W. Baird on Thursday, October 26 with “Hold”. RBC Capital Markets maintained Varian Medical Systems, Inc. (NYSE:VAR) rating on Thursday, November 30. RBC Capital Markets has “Hold” rating and $105.0 target. The company was maintained on Monday, January 23 by RBC Capital Markets.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: